Regulus Sets Hagan As COO

La Jolla-based microRNA biopharmaceuticals developer Regulkus Therapeutics said today that it has named Joseph P. "Jay" Hagan as its Chief Operating Officer, and also as Principal Financial Officer and Principal Accouting Officer. Hagan previously was Managing Director of Amgen Ventures, and also served as head of corporate development for Amgen, as CFO and Chief Business Officer at Orexigen Therapeutics, as well as Genzyme and Advanced Tissue Sciences.